Abstract
BackgroundGuidelines recommend foot orthoses for people with both early (< 2 years) and established rheumatoid arthritis (RA). While prefabricated foot orthoses are cheaper and can exhibit comparable effects to customised devices, the available evidence for their effectiveness is inconsistent. Little is known about what types of foot orthoses clinicians prescribe. This study describes the foot orthoses prescription habits of podiatrists for people with rheumatoid arthritis.MethodsOne hundred and eighty-three podiatrists from the United Kingdom (UK) (n = 88), Australia (n = 68) and New Zealand (n = 27) completed a self-administered, online survey regarding the types of foot orthoses prescribed in clinical practice for people with RA. This study forms part of a wider international survey exploring foot orthosis prescription habits.ResultsUK respondents were more likely to prescribe prefabricated orthoses for early RA (n = 47, 53%) and customised orthoses for established RA (n = 47, 53%). Respondents in Australia were more likely to prescribe customised orthoses for both early (n = 32, 47%) and established (n = 46, 68%) RA, whilst respondents in New Zealand were more likely to prescribe prefabricated orthoses for both early (n = 16, 59%) and established (n = 10, 37%) disease.Irrespective of disease stage, the use of foam impression boxes was more prevalent in the UK and New Zealand when capturing a model of the feet prior to manufacturing customised orthoses. In contrast, electronic scanning and plaster of Paris were more common in Australia. Computer aided manufacture was utilised more frequently among respondents in Australia than in the UK and New Zealand. Respondents in all three countries specified more flexible shell materials for established RA, compared to early disease. Cushioning top covers (e.g. PORON® or polyurethane) were most frequently specified in all countries for both disease stages.ConclusionsConsiderable variation was seen in the self-reported foot orthoses prescription habits of respondents for people with RA. Variation between countries and disease stage was seen in type of orthoses, specific brands, manufacturing methods, and materials prescribed. The results allow podiatrists and broader health service providers to compare their practice against reported national and international patterns.
Highlights
Guidelines recommend foot orthoses for people with both early (< 2 years) and established rheumatoid arthritis (RA)
The majority of respondents practised in the United Kingdom (47%, n = 124), Australia (30%, n = 79) and New Zealand (12%, n = 32)
Eighty-eight (71%) respondents in the United Kingdom (UK) indicated that they prescribed Foot orthoses (FOs) for people with RA
Summary
Guidelines recommend foot orthoses for people with both early (< 2 years) and established rheumatoid arthritis (RA). Foot orthoses (FOs) are frequently prescribed in clinical practice as an intervention for people with rheumatoid arthritis (RA), a chronic inflammatory disease with an estimated global prevalence of up to 1% [1]. Mechanical factors play a key role in the progression of foot deformity, and are increasingly thought to have a major role in the persistence of foot pathology [7,8,9] Mechanical therapies, such as foot orthoses (FOs), offload painful joints and periarticular structures and are used to reduce pain, disability, and improve quality of life in people with RA [10, 11]. FOs are widely recommended in key guidelines in the UK and Australia [14, 15]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.